Sign in

CIK 0001880438 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

AN2 Therapeutics, Inc.

Sign in to watch
Ticker
ANTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
820606654
Phone
(650) 331-9090
Business address
1300 EL CAMINO REAL, SUITE 100, MENLO PARK, CA, 94025
  1. DEF 14A Proxy Proxy Statement
  2. 424B5 Offering Prospectus
  3. EFFECT Other Notice of Effectiveness
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. UPLOAD Other SEC-generated Letter
  6. S-3 Offering Registration Statement
  7. S-8 Other Securities Offered to Employees in Benefit Plans
  8. 10-K Report Annual Report
  9. 8-K Event Results of operations
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. SC 13G/A Stake Amended Statement of Ownership
  18. SC 13G/A Stake Amended Statement of Ownership
  19. SC 13G/A Stake Amended Statement of Ownership
  20. SC 13G Stake Amended Statement of Ownership

Page 15 of 20 · 387 filings